Description du projet
Une cote de risque de cancer gastrique fondée sur l’IA
L’intelligence artificielle (IA) s’immisce de plus en plus dans les soins de santé afin d’améliorer l’évaluation des risques de maladie et de prédire les résultats cliniques ou thérapeutiques. Le projet AIDA, financé par l’UE, cherche à créer une cote de risque fondée sur l’IA pour le cancer gastrique, une maladie qui est généralement détectée à un stade avancé où les options thérapeutiques sont limitées. Les chercheurs combineront des données issues de différentes sources pour détecter les inflammations gastriques précancéreuses et produire une cote de risque de cancer gastrique. Cette approche améliorera les connaissances sur l’évolution de l’inflammation gastrique en cancer et aidera les cliniciens à formuler un plan de traitement personnalisé pour prévenir le cancer gastrique.
Objectif
Most cases of gastric cancer (GC) are detected at a late stage, when patients have a median life expectancy of about a year. Diagnosing people at risk of developing GC at the pre-symptomatic stage, typically chronic gastric inflammation, could significantly improve the outlook.
Artificial intelligence (AI) can help clinicians make sense of their own data by automating much of the treatment and analysis, which require manual work and years of experience. But it can do more: it can bring together available data from various sources into a vast data lake and cross-correlate the data to derive a ‘risk score’ for gastric cancer and shed light on the mechanisms of its evolution.
Aida aims to do just that. It helps researchers understand the mechanisms that trigger gastric oncogenesis, helps clinicians diagnose precancerous inflammation at the earliest possible stage, suggests personalised therapeutic strategies for treatment and follow-up, and makes personalised recommendations for monitoring patient health status, thus contributing to gastric cancer prevention.
This places Aida squarely on Europe’s agenda of ‘Staying healthy in a rapidly changing society’. Aida unites some of Europe’s leading authorities in the field of gastric inflammation, gastric cancer, leading AI and machine learning experts, experts on data governance and privacy, representatives of the public administration and patient advocates. Aida also has strong ties with the industry.
After the project, the results will live on in a foundation that acts as a transnational focal point for chronic gastric inflammation — and GC in general. We hope that the solid, inclusive design principles of Aida, its societal relevance and its durability will spawn a vigorous ecosystem around chronic gastric inflammation, its understanding and its treatment. And we hope that it will inspire other data collaboratives in health — for other chronic inflammations, other forms of cancer or other ailments altogether.
Champ scientifique
Mots‑clés
Programme(s)
Régime de financement
HORIZON-RIA - HORIZON Research and Innovation ActionsCoordinateur
46010 Valencia
Espagne